Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cellular & Molecular Biology Letters|October 30, 2007
Syntaxin 8 has two functionally distinct di-leucine-based motifsKazuo Kasai, Kei Suga, Tetsuro Izumi, et al.
Traffic (Copenhagen, Denmark)|April 10, 2008
Docking is not a prerequisite but a temporal constraint for fusion of secretory granulesKazuo Kasai, Takuji Fujita, Hiroshi Gomi, et al.
The Journal of Cell Biology|October 12, 2005
Granuphilin molecularly docks insulin granules to the fusion machineryHiroshi Gomi, Shin Mizutani, Kazuo Kasai, et al.
Cell Structure and Function|January 28, 2004
The roles of Rab27 and its effectors in the regulated secretory pathwaysTetsuro Izumi, Hiroshi Gomi, Kazuo Kasai, et al.
FEBS Letters|January 31, 2012
Novel assay with fluorescence-labelled PrP peptides for differentiating L-type atypical and classical BSEs, and scrapieKazuo Kasai, Akiyoshi Hirata, Takafumi Ohyama, et al.
Pathogens (Basel, Switzerland)|December 2, 2014
Heterogeneity of the Abnormal Prion Protein (PrPSc) of the Chandler Scrapie StrainKazuo Kasai, Yoshifumi Iwamaru, Kentaro Masujin, et al.
Molecular Biology of the Cell|December 11, 2012
The Rab27a effector exophilin7 promotes fusion of secretory granules that have not been docked to the plasma membraneHao Wang, Ray Ishizaki, Jun Xu, et al.
Plos One|March 8, 2013
The N-terminal sequence of prion protein consists an epitope specific to the abnormal isoform of prion protein (PrP(Sc))Kentaro Masujin, Yuko Kaku-Ushiki, Ritsuko Miwa, et al.
Molecular Biology of the Cell|December 22, 2006
Exophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique Ca2+-inhibitory phospholipid-binding activity of the C2A domainMiao Yu, Kazuo Kasai, Kazuaki Nagashima, et al.
Veterinary Research|June 25, 2011
Experimental H-type bovine spongiform encephalopathy characterized by plaques and glial- and stellate-type prion protein depositsHiroyuki Okada, Yoshifumi Iwamaru, Morikazu Imamura, et al.
Pageof 2